Biotest AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other
pharmaceutical manufacturers in Europe:
sales of 614.49 million Euro [US$663.59 million]
Recipharm AB (publ)
(4.68 billion Swedish Kronor [US$530.80 million]
based in the United Kingdom
(£447.50 million [US$557.98 million]
of which 37%
was Licensing & Biotechnology).
During the year ended December of 2016, sales at
Biotest AG were 553.10 million Euro (US$597.30 million).
decrease of 6.2%
versus 2015, when the company's sales were 589.60 million Euro.